Zai Lab (ZLAB) Share-based Compensation (2017 - 2026)

Zai Lab (ZLAB) posted quarterly Share-based Compensation of $13.5 million for Q1 2026, down 14.41% year-on-year from $15.8 million in Q1 2025, and down 14.95% on a QoQ basis from $15.9 million in Q4 2025.

Zai Lab (ZLAB) Share-based Compensation (2017 - 2026) Analysis & Trends

Zai Lab (ZLAB) has reported Share-based Compensation for 10 consecutive years, with $13.5 million the latest figure, recorded in Q1 2026.

  • Quarterly Share-based Compensation fell 14.41% year-over-year to $13.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $63.3 million (down 7.52% YoY) and the FY2025 annual result came in at $65.6 million, down 7.15% from the prior year.
  • Share-based Compensation eased to $13.5 million in Q1 2026 per ZLAB's latest filing, from $15.9 million in the prior quarter.
  • Over the last five years, Share-based Compensation for ZLAB reached as high as $22.0 million in Q3 2023 and fell as low as $12.4 million in Q1 2022.
  • A 5-year average of $17.1 million and a median of $16.9 million in 2025 frame the typical range for Share-based Compensation.
  • Annual changes were most pronounced in 2022 — Share-based Compensation soared 81.02% — and 2024, when it slipped 23.63%.
  • Year by year, Share-based Compensation stood at $15.6 million in 2022, then surged by 31.56% to $20.5 million in 2023, then fell by 15.79% to $17.2 million in 2024, then retreated by 7.75% to $15.9 million in 2025, then declined by 14.95% to $13.5 million in 2026.
  • According to Business Quant data, Share-based Compensation over the past three periods registered $13.5 million, $15.9 million, and $16.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 6.39 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9.26 Mn
4 NuCana 279.75 Bn 279.75 Bn - 1.18 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 166.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 257.40 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 87.30 Mn
10 Zai Lab 22.02 Bn 22.02 Bn 61.30 Mn 13.52 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 13.52 Mn
Mar 31, 2026 13.52 Mn
Dec 31, 2025 15.90 Mn
Dec 31, 2025 15.90 Mn
Sep 30, 2025 16.92 Mn
Sep 30, 2025 16.92 Mn
Jun 30, 2025 16.97 Mn
Jun 30, 2025 16.97 Mn
Mar 31, 2025 15.80 Mn
Mar 31, 2025 15.80 Mn
Dec 31, 2024 17.24 Mn
Dec 31, 2024 17.24 Mn
Sep 30, 2024 16.80 Mn
Sep 30, 2024 16.80 Mn
Jun 30, 2024 18.64 Mn
Jun 30, 2024 18.64 Mn
Mar 31, 2024 17.98 Mn
Mar 31, 2024 17.98 Mn
Dec 31, 2023 20.47 Mn
Dec 31, 2023 20.47 Mn